Medifron DBT Co. Ltd (065650) — Cash Flow Reinvestment Rate
Medifron DBT Co. Ltd (065650) has a Cash Flow Reinvestment Rate of 0.08x as of June 2025, reinvesting ₩522.85 Million (capex ₩22.85 Million plus investments ₩-500.00 Million) from operating cash flow of ₩6.72 Billion. Check 065650 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medifron DBT Co. Ltd Cash Flow Reinvestment Rate (2011–2014)
Historical reinvestment intensity for Medifron DBT Co. Ltd across 2 annual periods. Explore 065650 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Medifron DBT Co. Ltd (2011–2014)
Year-by-year capital reinvestment analysis for Medifron DBT Co. Ltd. For live market cap and broader valuation context, see 065650 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2014 | 1462.92x | ₩1.03 Billion | ₩701.96K | ₩26.91 Million | ▲ +94109.2% |
| 2011 | 1.55x | ₩1.42 Billion | ₩912.56 Million | ₩27.00 Million | — |